STOCKS TELEGRAPH

Tag: SenesTech Inc.

  • SenesTech (SNES) Stock Jumps In Pre-Market After Positive Financials

    SenesTech (SNES) Stock Jumps In Pre-Market After Positive Financials

    Shares of SenesTech, Inc. (NASDAQ: SNES) experienced a sharp increase in value on the stock charts following the disclosure of its financial results. As of the last check, the SNES shares were trading at $2.59, a 13.60% gain in pre-market trading.

    Revenue Growth and Financial Performance

    SenesTech’s Q4 2024 revenue jumped from $295,000 to $501,000, a significant 70% rise over the same quarter the previous year. The impressive 206% rise in e-commerce sales was a major factor in this surge.

    Additionally, the firm improved its net loss, which went from $1.7 million in Q4 2023 to $1.3 million. This development is a product of SNES’s continual efforts to strengthen operational performance and polish its business strategy.

    Expanding the Evolve Product Line

    One of SenesTech’s most noteworthy achievements in 2024 was the success of its Evolve product line. The Evolve Rat, a rodent reproductive control device, has rapidly become the company’s best-selling product, generating 52% of Q4 2024 revenue.

    Evolve Mouse, which SNES also introduced in May 2024, immediately produced 24% of Q4 revenue. These devices, which were developed by a number of online merchants such as Amazon, Walmart, and Tractor Supply, were made to proactively manage rodent populations.

    International Growth and Strategic Alliances

    With distribution agreements struck in 10 nations and territories, SenesTech’s worldwide presence is only getting stronger. Shipments to Hong Kong, the United Arab Emirates, the Netherlands, and the Maldives are noteworthy, while distribution activities in Australia, New Zealand, and India are almost finished.

    SenesTech also obtained a sizable order for their Evolve Rat product, which will be used in the rat contraceptive trial program in New York City starting in April. SNES is concentrating on increasing operational effectiveness and cutting expenses with these developments.

    With the anticipated $2 million in incremental yearly savings from new projects, SNES will be one step closer to reaching cash flow breakeven at a lower revenue barrier of $7 million, rather than the previously projected $12 million. SenesTech is positioned for long-term, sustainable development and profitability thanks to these actions.

  • SenesTech Inc. (SNES) stock rises during pre-market trading session. Here’s what’s happening?

    SenesTech Inc. (SNES) stock rises during pre-market trading session. Here’s what’s happening?

    SenesTech Inc. (NASDAQ: SNES) stock gained by 12.50% in the last trading close while the SNES stock keeps on rising by 2.02% during the pre-market trading session after SenesTech announced its collaboration with Liphatech. SenesTech is an agricultural biotechnology company that focuses on the management of fertility for pest control through different technologies. ContraPest is their first commercial which works to fight difficult rat outbreak.

    What’s happening?

    The purpose of collaboration between SenesTech and Liphatech is to develop a non-liquid formulation of ContraPest. Both SenesTech and Liphatech which is an internationally known researcher and distributor of unique and effective pest control products will equally participate to the project through providing resources and finances.

    ContraPest is a rat birth control product. Also it not just only eliminates rat infestations, but it also prevents them from returning. ContraPest has proven to be effective in reducing rat populations over the course of five years of research and implementation in municipal, agricultural, and commercial settings. ContraPest is currently available in a liquid formulation that has been approved by the Environmental Protection Agency.

    Furthermore,

    Brandy Pyzyna, the VP of SeneTech’s Research and Regulatory department said that their area of work will be comprised of all preparation, implementation, and testing to check the efficiency of the non-liquid formulation of ContraPest which is based on the soft bait matrix developed and advertised by Liphatech. Brandy also added that they have a comprehensive, collaborative work plan in place that they can implement right away.

    Conclusion

    This recent positive development in SenesTech has possibly acted as a great initiative for the progress of SNES. Also it has brought the focus of Investors towards the SNES stock. In the past as well, SenesTech through its ContraPest brand has shown great beneficial results whenever it has been linked with any Pest control program. Hence the expectations are high from this collaboration as well.